M
MedPass Brasil
Medical Intelligence to improve the health of its employees and impact its cost
About MedPass Brasil
MedPass Brasil, founded in 2016 by Hans J Apostel, operates in the corporate health and wellness sector in Brazil, providing a digital platform focused on personalized and preventative care for employees. The company positions itself as a strategic partner for businesses, primarily Small and Medium-sized Enterprises (SMEs), aiming to manage employee health, predict future healthcare expenses, and ultimately reduce costs associated with employee health issues.
The company's business model is centered on a B2B approach, offering its platform to corporate clients. These clients, in turn, provide the MedPass service to their employees. Employees start by completing digital assessments about their health conditions and habits within the MedPass application. This data generates managerial dashboards for the client's HR department, offering insights into the health and quality of life of their workforce, which helps guide population health management policies. The platform also includes messaging resources for HR to communicate with employees.
The service for employees is comprehensive. It features a "Health Center" with physicians and nurses available for chat or video consultations seven days a week. A key feature is a virtual assistant named "Ben," which uses over 120 medical algorithms to offer personalized screening and medical guidance based on the user's risk profile and digital medical records. Through the platform, healthcare professionals can access these records, prescribe medications, and order lab exams, which can be obtained at a discount through an accredited network. This integration of telehealth, risk assessment, and personalized monitoring aims to create structured, individualized health action plans.
MedPass Brasil has demonstrated significant traction in securing capital within Brazil's competitive health-tech market. The company secured an initial $8 million in seed funding starting in 2016, followed by a Series A commitment of $6 million announced in October 2020. This places it among the more substantially funded health-tech startups in the country. Notably, some sources indicate the company may be out of business as of May 2025, a detail that conflicts with other available data and requires careful consideration.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDEquity / VC | Aug 2021 | $3M | $12M | Undisclosed | — |
| EARLY VC✓Equity / VC | Oct 2020 | $6M | $40M | Undisclosed | — |
Growth signals
Latest recorded traffic for MedPass Brasil is 110 monthly website visits, down 64.5% over the last three months. MedPass Brasil's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MedPass Brasil in the São Paulo ecosystem
The MedPass Brasil office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedPass Brasil on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedPass Brasil’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










